Solanum incanum extract downregulates aldehyde dehydrogenase 1-mediated stemness and inhibits tumor formation in ovarian cancer cells

Journal of Cancer

Volumn 6, Issue 10, 2015, Pages 1011-1019

  Wu, Yi Hui ^a   Chiu, Wen Tai ^b   Young, Ming Jer ^a   Chang, Tzu Hao ^c   Huang, Yu Fang ^a   Chou, Cheng Yang ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Aldehyde dehydrogenase 1; Chemoresistance; Ovarian cancer; Solanum incanum; Stemness

Indexed keywords

ALDEHYDE DEHYDROGENASE ISOENZYME 1; ANTINEOPLASTIC AGENT; CCAAT ENHANCER BINDING PROTEIN BETA; CISPLATIN; COLLAGEN TYPE 1; COLLAGEN TYPE 1 ALPHA 1; FORKHEAD BOX PROTEIN M1; FORKHEAD TRANSCRIPTION FACTOR; NOTCH1 RECEPTOR; PACLITAXEL; SR T 100; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BINDING SITE; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER INHIBITION; CANCER RESISTANCE; CANCER SIZE; CARCINOGENESIS; CELL COUNT; CELL DIFFERENTIATION; CELL GROWTH; CELL VIABILITY; CHEMOSENSITIVITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG CYTOTOXICITY; DRUG POTENTIATION; DRUG SENSITIVITY; ENZYME ACTIVITY; ENZYME REPRESSION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE CONTROL; GROWTH INHIBITION; HUMAN; HUMAN CELL; IC50; IN VITRO STUDY; MONOTHERAPY; MOUSE; NONHUMAN; OVARIAN CANCER CELL LINE; OVARY CANCER; PROTEIN EXPRESSION; SOLANUM INCANUM;

EID: 84947716780     PISSN: None     EISSN: 18379664     Source Type: Journal    
DOI: 10.7150/jca.12738     Document Type: Article

References (32)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. Cancer J Clin 2012; 62: 10-29.
2. Cho KR and Shih IM. Ovarian cancer. Annu Rev Pathol 2009; 4: 287-313.
3. Heidegger I, Massoner P, Eder IE, et al. Novel therapeutic approaches for the treatment of castration-resistant prostate cancer. J Steroid Biochem Mol Biol 2013; 138C: 248-256.
4. Alberti C. Taxane-and epothilone-based chemotherapy: from molecule cargo cytoskeletal logistics to management of castration-resistant prostate carcinoma. Eur Rev Med Pharmacol Sci 2013; 17: 1658-1664.
5. Meiyanto E, Hermawan A, Anindyajati. Natural products for cancer-targeted therapy: citrus flavonoids as potent chemopreventive agents. Asian Pac J Cancer Prev 2012; 13: 427-436.
6. Cham BE, Gilliver M, Wilson L. Antitumour effects of glycoalkaloids isolated from Solanum sodomaeum. Planta Med 1987; 53: 34-36.
7. Cham BE, Meares HM. Glycoalkaloids from Solanum sodomaeum are effective in the treatment of skin cancers in man. Cancer Lett 1987; 36: 111-118.
8. Kupchan SM, Barboutis SJ, Knox JR, Cam CA. Beta-solamarine: tumor inhibitor isolated from Solanum dulcamara. Science 1965; 150: 1827-1828.
9. Cham BE, Daunter B. Solasodine glycosides. Selective cytotoxicity for cancer cells and inhibition of cytotoxicity by rhamnose in mice with sarcoma 180. Cancer Lett 1990; 55: 221-225.
10. Lee KR, Kozukue N, Han JS, et al. Glycoalkaloids and metabolites inhibit the growth of human colon (HT29) and liver (HepG2) cancer cells. J Agric Food Chem 2004; 52: 2832-2839.
11. Liang CH, Shiu LY, Chang LC, Sheu HM, Kuo KW. Solamargine upregulation of Fas, downregulation of HER2, and enhancement of cytotoxicity using epirubicin in NSCLC cells. Mol Nutr Food Res 2007; 51: 999-1005.
12. Chiu HF, Lin CC, Yang CC, Yang F. The pharmacological and pathological studies on several hepatic protective crude drugs from Taiwan (II). Am J Chin Med 1989; 17: 17-23.
13. Chang LC, Tsai TR, Wang JJ, Lin CN, Kuo KW. The rhamnose moiety of solamargine plays a crucial role in triggering cell death by apoptosis. Biochem Biophys Res Commun 1998; 242: 21-25.
14. Hsu SH, Tsai TR, Lin CN, Yen MH, Kuo KW. Solamargine purified from Solanum incanum Chinese herb triggers gene expression of human TNFR I which may lead to cell apoptosis. Biochem Biophys Res Commun 1996; 229: 1-5.
15. Kuo KW, Hsu SH, Li YP, et al. Anticancer activity evaluation of the solanum glycoalkaloid solamargine. Triggering apoptosis in human hepatoma cells. Biochem Pharmacol 2000; 60: 1865-1873.
16. Liang CH, Liu LF, Shiu LY, Huang YS, Chang LC, Kuo KW. Action of solamargine on TNFs and cisplatin-resistant human lung cancer cells. Biochem Biophys Res Commun 2004; 322: 751-758.
17. Liu LF, Liang CH, Shiu LY, Lin WL, Lin CC, Kuo KW. Action of solamargine on human lung cancer cells-enhancement of the susceptibility of cancer cells to TNFs. FEBS Lett 2004; 577: 67-74.
18. Shiu LY, Chang LC, Liang CH, Huang YS, Sheu HM, Kuo KW. Solamargine induces apoptosis and sensitizes breast cancer cells to cisplatin. Food Chem Toxicol 2007; 45: 2155-2164.
19. Hu K, Kobayashi H, Dong A, Jing Y, Iwasaki S, Yao X. Antineoplastic agents. III. Steroidal glycosides from Solanum nigrum. Planta Med 1999; 65: 35-38.
20. Wu CH, Liang CH, Shiu LY, et al. Solanum incanum extract (SR-T100) induces human cutaneous squamous cell carcinoma apoptosis through modulating tumor necrosis factor receptor signaling pathway. J Dermatol Sci 2011; 63: 83-92.
21. Zhang S, Balch C, Chan MW, et al. Identification and characterization of ovarian cancer-initiating cells from primary human tumors. Cancer Res 2008; 68: 4311-4320.
22. Gentleman C, et al. R. affyQCReport: QC Report Generation for affyBatch objects. 2005.
23. Gautier L, Cope L, Bolstad BM, Irizarry RA. Affy-analysis of Affymetrix GeneChip data at the probe level. Bioinformatics 2004; 20: 307-315.
24. Wu YH, Wu TC, Liao JW, et al. p53 dysfunction by xeroderma pigmentosum group C defects enhance lung adenocarcinoma metastasis via increased MMP1 expression. Cancer Res 2010; 70: 10422-10432.
25. Mahapatra S, Karnes RJ, Holmes MW, et al. Novel molecular targets of Azadirachta indica associated with inhibition of tumor growth in prostate cancer. AAPS J 2011; 13: 365-77.
26. Sullivan, JP, Spinola M, Dodge M, et al. Aldehyde dehydrogenase activity selects for lung adenocarcinoma stem cells dependent on notch signaling. Cancer Res 2010; 70: 9937-9948.
27. Jiang, LY, Zhang XL, Du P, Zheng JH. Gamma-secretase inhibitor, DAPT inhibits self-renewal and stemness maintenance of ovarian cancer stem-like cells in vitro. Chin J Cancer Res 2011; 23: 140-146.
28. Chiu WT, Huang YF, Tsai HY, et al. FOXM1 confers to epithelial-mesenchymal transition, stemness and chemoresistance in epithelial ovarian carcinoma cells. Oncotarget 2015; 6: 2349-2365.
29. Wu YH, Chang TH, Huang YF, Chen CC, Chou CY. COL11A1 confers chemoresistance on ovarian cancer cells through the activation of Akt/c/EBPβ pathway and PDK1 stabilization. Oncotarget 2015, Accepted.
30. Hu K, Kobayashi H, Dong A, Jing Y, Iwasaki S, Yao X. Antineoplastic agents. III: Steroidal glycosides from Solanum nigrum. Planta Med 1999; 65: 35-38.
31. Young MJ, Wu YH, Chiu WT, Weng TY, Huang YF, Chou CY. All-trans retinoic acid downregulates ALDH1-mediated stemness and inhibits tumour formation in ovarian cancer cells. Carcinogenesis 2015; accepted.
32. Li X, Zhao Y, Ji M, Liu SS, Cui M, Lou HX. Induction of actin disruption and downregulation of P-glycoprotein expression by solamargine in multidrug-resistant K562/A02 cells. Chin Med J (Engl) 2011; 124: 2038-2044.